Vitamin C, Helicobacter pylori infection and gastric carcinogenesis

International Journal for Vitamin and Nutrition Research

Volumn 69, Issue 3, 1999, Pages 220-227

  Reed, Peter J ^a  

^a WEXHAM PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HELICOBACTER; HELICOBACTER PYLORI;

EID: 0033136467     PISSN: 03009831     EISSN: None     Source Type: Journal    
DOI: 10.1024/0300-9831.69.3.220     Document Type: Conference Paper

References (71)

1. Marshall, B. J. and Warren, J. R. (1983) Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet i, 1273-1275.
2. Warren, J. R. and Marshall, B. J. (1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet i, 1311-1315.
3. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease (1994) Helicobacter pylori in peptic ulcer disease. JAMA 272, 65-69.
4. International Agency for Research on Cancer (1994) IARC Monographs on the evaluation of carcinogenic risks to humans: Schistosomes, liver flukes and Helicobacter pylori. 61 pp. 177-220, IARC, Lyon.
5. Graham, D. Y., Klein, P. D., Evans, D. et al (1992) Helicobacter pylori: epidemiology, relationship to gastric cancer and the role of infants in transmission. Eur. J. Gastroenterol. Hepatol. 4 (Suppl. 1), 1-6.
6. Graham, D. Y. (1991) Helicobacter pylori: its epidemiology and its role in duodenal ulcer disease. J. Gastroenterol. Hepatol. 6, 105-113.
7. Parsonnet, J. (1995) The incidence of Helicobacter pylori infection. Aliment. Pharmacol. Ther. 9 (Suppl. 2), 45-51.
8. Asaka, M., Kimura, T., Kudo, M., et al (1992) Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 102, 760-766.
9. Huang, J.-Q., Sridhar, S., Chen, Y. and Hunt, R. H. (1996) Meta analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 110, A532.
10. Forman, D., Webb, P. and Parsonnet, J. (1994) Helicobacter pylori and gastric cancer. Lancet 343, 243-244.
11. Holcombe, C. (1992) Helicobacter pylori: The African enigma. Gut 33, 429-431.
12. Azuma, T., Ito, Y., Miyaji, H., Dojyo, M., Tanaka, Y., Hirai, M., Ito, S., Kato, T. and Kohli, Y. (1995) Immunogenetic analysis of the human leukocyte antigen DQA1 locus in patients with duodenal ulcer or chronic atrophic gastritis harbouring Helicobacter pylori. Eur. J. Gastroent. Hepatol. 7 (Suppl. 1), S71-73.
13. Beales, I. L. P., Davey, N. J., Pusey, C. D., Lechler, R. I. and Calam, J. (1995) Long term sequelae of Helicobacter pylori gastritis. Lancet 346, 381-382.
14. Fuchs, C. S. and Mayer, R. J. (1995) Gastric carcinoma. New. Engl. J. Med. 333, 32-41.
15. Kono, S. and Hirohata, T. (1996) Nutrition and stomach cancer. Cancer Causes and Control 7, 41-55.
16. Joossens, J. V., Hill, M. J., Elliott, P., Stamler, R., Lesaffre, E., Dyer, A., Nichols, R. and Kesteloot, H. (1996) Dietary salt, nitrate and stomach cancer mortality in 24 countries. Int. J. Epidemiol. 25, 494-504.
17. Block, G., Patterson, B., Subar, A. (1992) Fruit, vegetables and cancer prevention. A review of the evidence. Nutr. Cancer 18, 1-29.
18. Tsugane, S., Kabuto, M., Imai, H., Gey, E, Tei, Y., Hanaoka, T., Sugano, K. and Watanabe, S. (1993) Helicobacter pylori, dietary factors and atrophic gastritis in five Japanese populations with different gastric cancer mortality. Cancer Causes and Control 4, 297-305.
19. Kuipers, E. J., Pérez-Pérez, G. I., Meuwissen, S. G. M. and Blaser, M. J. (1995) Helicobacter pylori and atrophic gastritis: importance of the cagA status. J. Natl. Cancer. Inst. 87, 1777-1780.
20. Crabtree, J. E., Forman, D., Webb, P., et al for the EUROGAST Study Group (1997) An association between CagA positive H. pylori infection and the serum pepsinogens A:C ratio: evidence from an international cross-sectional study. Gut 41 (Suppl. 1) A47.
21. Blaser, M. J., Pérez-Pérez, G. I., Kleanthous, H., Cover, T. L., Peek, R. M., Chyou. P. H., Stemmermann, G. N. and Nomura A (1995) Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 55, 2111-2115.
22. Parsonnet, J., Friedman, G. D., Orentreich, N. and Vogelman, H. (1997) Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 40, 297-301.
23. Tokumaru, K., Kojima, T., Satoh, K., et al (1997) CagA gene of Helicobacter pylori is not a carcinogenic marker in Japanese patients. Gut 41, A47.
24. Ng, T. M., Fock, K. M., Khim, M. M., et al (1997) Gastric cancer and H. pylori infection in Singapore: Lack of association with CagA status. Gut 41, A47-48.
25. Letley, D. P., Lastovica, A., Louw, J. A., Hawkey, C. J. and Atherton, J. C. (1998) Diversity in vacA of Helicobacter pylori strains from South Africa: Lack of the pathogenic vacA sla genotype and discovery of a vacA s2/m1 allele. Gut 42 (Suppl. 1), A4.
26. Atherton, J. C. (1997) Helicobacter pylori unmasked - the complete genome sequence. Eur. J. Gastroent. Hepatol. 9, 1137-1140.
27. Genta, R. M. (1995) Helicobacter pylori as a promoter of intestinal metaplasia and gastric cancer: an alluring hypothesis in search of evidence. Eur. J. Gastroent. Hepatol. 7 (Suppl. 1), S25-S30.
28. Filipe, M. I., Muñoz, N., Matko, I., Kato, I., Pompe-Kirn, V., Jutersek, A., Teuchmann, S., Benz, M. and Prijon, T. (1994) Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int. J. Cancer 57, 324-329.
29. Kuipers, E. J. (1998) Review article: relationship between Helicobacter pylori, atrophic gastritis and gastric cancer. Aliment. Pharmacol. Ther. 12 (Suppl. 1), 25-36.
30. Blanchard, T. G., Czinn, S. J. (1998) Review article: immunological determinants that may affect the Helicobacter py/ori cancer risk. Aliment. Pharmacol. Ther. 12 (Suppl. 1), 83-90.
31. Sipponen, P., Kekki, M., Haapakoski, J., Ihamaki, T. and Siurala, M. (1985) Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int. J. Cancer 35, 173-177.
32. Kato, I., Tominaga, S., Ito, Y., Kobayashi, S., Yoshii, Y., Matsuura, A., Kameya, A., Kano, T. and Ikari, A. (1992) A prospective study of atrophic gastritis and stomach cancer. Jpn. J. Cancer Res. 83, 1137-1142.
33. Valle, J., Kekki, M., Sipponen, P., Ihamäki, T. and Siurala, M. (1996) Long-term course and consequences of Helicobacter pylori gastritis. Scand. J. Gastroenterol. 31, 546-550.
34. Correa, P., Haenszel, W., Cuello, C., Zavala, D., Fontham, E., Zarama, G., Tannenbaum, S., Collazos, T. and Ruiz, B. (1990) Gastric precancerous process in a high risk population: cohort follow up. Cancer Res. 50, 4737-4740.
35. Craanen, M. E., Dekker. W., Blok, P., Ferwerda, J. and Tytgat, G. N. J. (1992) Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. Gut 33, 16-20.
36. Filipe, M. I., Newell, D. G., Johnston, B. J., Caygill, C. and Reed P. I. for the UK Sub-group of the ECP-EURONUT Intestinal Metaplasia Study Group (1995) Helicobacter pylori in patients with intestinal metaplasia and in controls: a serological and biopsy study in four UK centres. Eur. J. Cancer Prev. 4, 175-180.
37. Sugimura, T., Matsukura, N. and Sato, S. (1982) Intestinal metaplasia of the stomach as precancerous stage. In: Host Factors in Human Carcinogenesis (Bartsch, H., Armstrong, B., Davis, W., eds.), p. 515-530 IARC Scientific Publications no 39, IARC, Lyon.
38. Houghton, P. W., Mortensen, N. J., Thomas, W. E., Cooper, M. J., Morgan, A. P. and Burton, P. (1986) Intragastric bile acids and histological changes in gastric mucosa. Br. J. Surg. 73, 354-356.
39. Sobala, G. M., O'Connor, H. J., Dewar, E. P., King, R. F., Axon, A. T. and Dixon, M. F. (1993) Bile reflux and intestinal metaplasia in gastric mucosa. J. Clin. Pathol. 46, 235-240.
40. Parsonnet, J., Friedman, G. D., Vandersteen, D. P., Chang, Y., Vogelman, J. H., Orentreich, N. and Sibley, R. K. (1991) Helicobacier pylori infection and the risk of gastric carcinoma. New Engl. J. Med. 325, 1127-1131.
41. Forman, D. (1995) The prevalence of Helicobacter pylori infection in gastric cancers. Aliment. Pharmacol. Ther. 9 (Suppl. 2), 71-76.
42. Correa, P., Haenszel, W., Cuello, C., Tannenbaum, S. and Archer, M. (1975) A model for gastric cancer epidemiology. Lancet ii, 58-60.
43. Correa, P. (1992) Human gastric Carcinogenesis: a multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 52, 6735-6740.
44. Ohshima, H. and Bartsch, H. (1981) Quantitative estimations of endogenous nitrosation in humans by monitoring of N-nitrosoproline excreted in the urine. Cancer Res.41, 3658-3662.
45. Xu, G. P. and Reed, P. I. (1993) N-Nitroso compounds in fresh gastric juice and their relation to intragastric pH and nitrite by employing an improved analytical method. Carcinogenesis 14, 2547-2551.
46. Reed, P. I., Smith, P. L. R., Haines, K., House, F. R. and Walters, C. L. (1981) The gastric juice N-nitrosamines in health and gastroduodenal disease. Lancet ii, 550-552.
47. Reed, P. I., Xu, G. P., Li, D. H., Hill, M. J. and Johnston, B. J. (1993) N-nitroso compound levels in fresh gastric juice in relation to clinical diagnosis. Gut 34 (Suppl. 2), S30.
48. Reed, P. I., Shen, Z. Z., Johnston, B. J. and Hill, M. J. (1995) Total N-nitroso compounds (TNNC) concentration correlates with increasing risk of gastric cancer. Gut 37 (Suppl. 2), A35.
49. Reed, P. I., Johnston, B. J., Walters, C. L. and Hill, M. J. (1991) Effect of ascorbic acid on the intragastric environment in patients at increased risk of developing gastric cancer. In: Relevance to Human Cancer of N-Nitroso Compounds, Tobacco Smoke and Mycotoxins (O'Neill, I. K., Chen, J., Bartsch, H., eds.), pp 139-142, IARC Sci. Publ. No. 105; IARC, Lyon.
50. Fontham, E. T. H. (1997) Prevention of upper gastrointestinal tract cancers. In: Preventive Nutrition: The Guide for Health Professionals (Bendrick, A., Deckelbaum, R.J., eds.), pp. 33-54 Humana Press, Totowa, N.J.
51. Correa, P., Malcom, G., Schmidt, B., Fontham, E., Ruiz, B., Bravo, J. C., Bravo, L. E., Zarama, G. and Realpe, J. L. (1998) Review article: antioxidant micronutrients and gastric cancer. Aliment. Pharmacol. Ther. 12 (Suppl. 1), 73-82.
52. Stähelin, H. B., Gey, K. F., Eichholzer, M., Ludin, E., Bernasconi, F., Thurneysen, J. and Brubacher, G. (1991) Plasma antioxidant vitamins and subsequent cancer mortality in the 12 year follow up of the prospective Basel study. Am. J. Epidemiol. 133, 766-775.
53. Ocké, M. C., Kromhout, D., Menotti, A., Aravanis, C., Blackburn, H., Buzina, R., Fidanza, F., Jansen, A., Nedeljkovic, S., Nissienen, A. et al (1995) Average intake of antioxidant (pro) vitamins and subsequent cancer mortality in the 16 cohorts of the Seven Countries Study. Int. J. Cancer 61, 480-484.
54. Sobala, G. M., Schorah, C. J., Sanderson, M. et al (1989) Ascorbic acid in the human stomach. Gastroenterology 97, 357-364.
55. Schorah, C. J., Sobala, G. M., Sanderson, M., Collis, N. and Primrose, J. N. (1991) Gastric juice ascorbic acid: effects of disease and implications for gastric carcinogenesis. Am. J. Clin. Nutr. 53, 2875-2934.
56. Drake, I. M., Davies, M. J., Mapstone, N. P., Dixon, M. F., Schorah, C. J., White, K. L., Chalmers, D. M. and Axon, A. T. (1996) Ascorbic acid may protect against human gastric cancer by scavenging mucosal oxygen radicals. Carcinogenesis 17, 559-562.
57. Correa, P., Malcom, G., Fontham, E, et al (1997) H. pylori and the metabolism of vitamin C. Gut 41 (Suppl. 1), A48.
58. Ruiz, B., Rood, J. C., Fontham, E. T., Malcom, G. T., Hunter, F. M., Sobhan, M., Johnson, W. D. and Correa, P. (1994) Vitamin C concentration in gastric juice before and after anti-Helicobacter pylori treatment. Am. J. Gastroent. 89, 533-539.
59. Rokkas, T., Papotheodorou, G., Karameris, A., Maurogeorgis, A., Kalogeropoulos, N. and Giannikos, N. (1995) Helicobacter pylori infection and gastric juice vitamin C levels, Dig. Dis. Sci. 40, 615-621.
60. Griffiths, A. E., Thuroz, M. R. and Walker, M. M. (1997) Do intestinal metaplasia and gastric atrophy reverse after H. pylori eradication? Gut 41 (Suppl. 1), A48-49.
61. Van der Hulst, R. W. M., Rauws, E. A. J. et al (1997) The influence of cure of H. pylori infection on the long term sequelae of gastritis: A prospective long term follow up study. Gut 41, (Suppl. 1), A54.
62. Pasztorova, I., Chinyama, C., Filipe, M. I., Smith, P. and Sanderson, J. D. (1997) Regression of gastric intestinal metaplasia after eradication of Helicobacter pylori: A prospective study. (1997) Gut 41 (Suppl. 1), A55-56.
63. de Sanjosé, S., Muñoz, N., Sobala, G., Vivas, J., Peraza, S., Cano, E., Castro, D., Sanchez, V., Andrade, O., Tompkins, D., Schorah, C. J., Axon, A. T., Benz, M., Oliver, W. (1996) Antioxidants, Helicobacter pylori and stomach cancer in Venezuela. Eur. J. Cancer Prev. 5, 57-62.
64. Waring, A. J., Drake, I. M., Schorah, C. J., White, K. L., Lynch, D. A., Axon, A. T. and Dixon, M. F. (1996) Ascorbic acid and total vitamin C concentrations in plasma, gastric jucie, and gastrointestinal mucosa: effects of gastritis and oral supplementation. Gut 38, 171-176.
65. Mannick, E. E., Bravo, L. E., Zarama, G., Realpe, J. L., Zhang, X. J., Ruiz, B., Fontham, E. T., Mera, R., Miller, M. J. and Correa, P. (1996) Inducible nitric oxide synthase, nitro-tyrosine, and apoptosis in Helicobacter pylori gastritis: Effect of antibiotics and anti-oxidants. Cancer Res. 56, 3238-3243.
66. Zhang, H.-M., Wakisaka, N., Maeda, O. and Yamamoto, T. (1997) Vitamin C inhibits the growth of a bacterial risk factor for gastric carcinoma: Helicobacter pylori. Cancer 80, 1897-1903.
67. Phull, P. S., Price, A. B., White, K., Schorah, C. J., Jacyna, M. R. (1996) Gastric mucosal vitamin C levels in Helicobacter pylori infection. Gut 38 (Suppl. 1), A3.
68. Reed, P. I. and Johnston, B. J. (1995) Primary prevention of gastric cancer. Acta Endoscop. 25, 45-54.
69. Buiatti, E., Muñoz, N., Vivas, J., Cano, E., Peraza, S., Carillo, E., Castro, D., Sanchez, V., Andrade, O., Benz, M., et al (1994) Difficulty in eradicating Helicobacterpylori in a population at high risk for stomach cancer in Venezuela. Cancer Causes and Control 5, 249-254.
70. Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group (1994) The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N. Engl. J. Med. 330, 1029-1035.
71. Forman, D. (1998) Lessons from ongoing intervention studies. In: Helicobacter pylori: Basic Mechanisms to Clinical Cure (Hunt, R., Tytgat, G., eds.), Kluwer Academic Publishers, Amsterdam (in press).